The influence of a-hederin (a saponin isolated from Hedera helix), chlorophyllin, the sodium-copper salt of chlorophyll, and ascorbic acid (vitamin C) on the direct clastogenicity of doxorubicin (Adriamycin®) was investigated in vitro in human lymphocytes for the induction of micronuclei. In order to determine a possible mechanism of action responsible for the antimutagenic activity, treatments were performed for the three substances at different times of the culture (pre-treatment, simultaneous and post-treatment). Alpha-hederin (UxlO" 2 , 0.13, 13 and 13 nmol/ml) and chlorophyllin (0.14, 1.4 and 14 nmol/ml) were found to exert an antimutagenic effect against the clastogenicity of doxorubicin (UxlO" 2 nmol/ml) in all treatments at all concentrations. Ascorbic acid (10 nmol/ml) was effective in reducing the micronucleus levels only in the simultaneous treatment, when it was previously incubated with doxorubicin for 2 h at 37°C before being introduced into the culture. Our results suggested a desmutagenic effect for a-hederin, chlorophyllin and ascorbic acid. Chlorophyllin acted also through a bio-antimutagenic mechanism and a-hederin seemed to induce metabolic enzymes, which inactivated doxorubicin. Preliminary studies showed sthat the effective antimutagenic concentrations of a-hederin, chlorophyllin and ascorbic acid had no clastogenic or aneugenic effects in human lymphocytes. No cytotoxicity was observed for the three antimutagenic agents either.
Introduction
Diet is a complex mixture of chemicals; it can contain mutagens and carcinogens but it may also contain substances which can prevent mutagenesis and carcinogenesis (Hayatsu et ai, 1988) . In 1983, Ames reported that some natural substances possess factors which can reduce or inhibit the activity of mutagens in the human diet. Several mutagenesis inhibitors, e.g. ellagic acid, palmitoleic acid and JV-acetylcysteine, have also been demonstrated to be carcinogenesis inhibitors, suggesting that the search of antimutagenic agents may be useful for discovering anticarcinogenic agents. Finding inhibitors and studying their mechanisms of action has become important in providing humans with preventive measures against cancer. The easiest way to obtain protection is from natural inhibitors present in the diet, but it can also be provided by non-edible plants, especially those already known for their pharmacological activity.
Short-term mutagenicity assays have been used effectively to screen for mutagens and potential carcinogens in the human environment. The same procedures are used to identify antimutagens and potential anticarcinogens. Cultures of human peripheral lymphocytes, a classical system in cytogenetic mutagenicity testing, have proved suitable for such studies (Gebhart, 1992; Kuroda et ai, 1992) . In mutagenicity testing, the cytokinesis-block micronucleus assay represents an alternative to other cytogenetics assays for assessing genetic damage which can detect both chromosomal (clastogenic effect) and genomic (aneugenic effect) mutations (Fenech, 1993) .
Besides their general biological importance, some vitamins, in particular vitamins C and E (ascorbic acid and a-tocopherol respectively), have been shown to be effective protectors against the detrimental effects of cytostatics, as well as against the carcinogenic activity of ionizing radiations and chemical agents in experimental systems (Gebhart et ai, 1985) . Ascorbic acid is a well known antioxidant and scavenger of free radicals, effective in inhibiting formation of genotoxic nitroso compounds both in vitro and in vivo (Mirvish, 1986; Ramel et ai, 1986) .
Chlorophyllin, the sodium copper-salt of chlorophyll, a wellknown food additive (E.141) which is also used in gastrointestinal medicine and for the acceleration of wound healing (Imai et ai, 1986) , has been shown to reduce the mutagenic activities of known mutagens and complex mixtures (Ong etai, 1989) . Using the Salmonella/microsomal assay, a-hederin, a saponin isolated from Hedera helix with antifungal and antihelminthic activities (Balansard et ai, 1980; Julien et ai, 1985) , and chlorophyllin have been shown to exert an antimutagenic effect against benzo[a]pyrene, a well known pro-mutagenic compound (Elias et ai, 1990) .
In the present study we investigated whether a-hederin, chlorophyllin and ascorbic acid have an antimutagenic effect in human lymphocytes in vitro, using the cytokinesis-block micronucleus assay. For this purpose, an adapted protocol of treatment was used to examine the decrease in the micronucleus levels induced by the clastogen doxorubicin, commonly used as a chemotherapeutic drug, and to examine a possible mechanism of the antimutagenic effect (Kada, 1983; Kada and Shimoi, 1987; De Flora and Ramel, 1988; Shankel et ai, 1993) . (Table I) a-Hedenn (sodium salt) was kindly provided by Professor G.Balansard (Faculte de Pharmacie, Marseille, France). Chlorophyllin (sodium-copper salt) and L-ascorbic acid were purchased from Sigma Chemical Co. (St Louis, MO) and dissolved in water just before use. Cytochalasin B (Sigma) was dissolved in dimethyl sulphoxide at a concentration of 5X1O 1 nmol/ml and kept at -20°C. Doxorubicin and colchicine were purchased from Carlo Erba (Reuil Malmaison, France) and Biological Industries (Kibbutz Beit Haemek, Israel) respectively.
Materials and methods

Chemicals
Blood samples
Human blood samples were obtained by venipuncture from 11 healthy donors not exceeding 35 years in age. Blood was collected in glass tubes containing lithium hepann as an anticoagulant. Donors who showed an unusually high frequency of >16 per thousand binucleated lymphocytes with micronuclei were not used. 
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Preparation of cultures
Cultures were set up by adding 0.7 ml of whole blood to 6.4 ml of 199 medium (Biological Industries) supplemented with 25% fetal calf serum (Eurobio, Toulouse, France) and antibiotics (penicillin and streptomycin), stimulated with 2% of phytohaemagglutinin (PHA; Biochrom-Seromed, Leonorenstr, Berlin, Germany) and incubated for 72 h at 37°C.
Cytotoxicity assay
To evaluate the cytotoxic effect of each antimutagenic substance, colchicine (25 nmol/ml) was added to the cultures 2 h prior to harvesting, in order to arrest metaphases.
Cytokinesis-block micronucleus assay
Cytochalasin B was added to the cultures 44 h after PHA stimulation at a final concentration of 10 nmol/ml. Cultures were harvested 28 h after cytochalasin B addition, as shown in Figure 1A .
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Treatment Antimutagenic agents were added to the cultures 24 h after PHA stimulation (mid-G! phase; Watt and Stephen, 1986 ) and left until harvest for both the cytotoxicity and cytokinesis-block micronucleus assays. Two cultures were made in parallel for controls. In the protocol used to screen for the antimutagenic activity, antimutagenic substances were added to cultures at the following concentrations: a-hedenn, 1.3X10" 2 , 0.13, 1.3 and 13 nmol/ml, chlorophyllin, 0.14, 1.4 and 14 nmol/ml; and ascorbic acid, 10 nmol/ml.
The standard final concentration of the clastogenic agent doxorubicin, defined by preliminary tests, was 1.5X10" 2 nmol/ml. The interindividual variation in sensitivity to 1.5X 10~2 nmol/ml of doxorubicin was investigated and all donors (lower and upper values of induced micronuclei were 20 and 57 respectively) were found to be in agreement with threshold values determined in our laboratory (lower and upper limits 12 and 69, respectively, determined in a population of 50 donors). In the same protocol, the clastogenic and antimutagenic agents were introduced at different times into the cultures (Kuroda et al., 1992) , as shown in Figure IB .
The antimutagenic substance was added at the beginning of the culture with PHA in pre-treatment la, at 18 h in pre-treatment Ib and at 24 h in pretreatment Ic. The clastogenic agent was added at 24 h in pre-treatment la and Ib, and at 26 h in pre-treatment Ic.
In simultaneous treatment without pre-incubation (lib), anumutagenic and clastogenic agents were added simultaneously at 24 h. When pre-incubation was performed (Ha), a pre-incubating mixture (2 h at 37°C) of the antimutagenic substance with the clastogenic one was introduced into the culture at 24 h.
The clastogenic agent was introduced into the culture at 24 h, followed by the antimutagenic agent at 26 h in post-treatment Ilia and at 27 h in posttreatment Illb.
Harvesting and slide preparation
Cultures were harvested after a 72 h incubation period. In the cytotoxicity assay, cells were resuspended after 10 mm centnfugation in prewarmed hypotonic solution (0.075 M KCI at 37°C) for 12 min. After a 10 min centrifugation, cells were fixed in a fresh fixative solution (methanohacetic acid 3:1). After a second fixation in a methanol:acetic acid solution (3.1) cells resuspended in a small volume of the fixative were dropped onto clean slides, air-dned and stained with a 4% Giemsa solution.
In the cytokinesis-block micronucleus assay, cells were treated by a mild hypotonic treatment (2 min in 0.075 M KCI) and immediately fixed with methanol:acetic acid (3:1). This fixation step was repeated twice after 20 min storage at 4°C. Cells were smeared on precleaned slides and air-dried. Staining was achieved with 4% Giemsa in SOrensen buffer, pH 6.8, for 15 min.
Analysis
Stained preparations were coded and scored by light microscopy at X400 magnification For each slide, a total of 1000 binucleated lymphocytes with preserved cytoplasm were analysed for the presence of one, two or three or more micronuclei and expressed per thousand micronucleated binucleated cells (MNCB). Micronuclei were identified according to the following criteria: they were morphologically identical to the normal nuclei but smaller (their diameter between 1/16 and 1/3 of the main nuclei), non-refractile, not linked to the main nuclei via a nucleoplasmic bridge and sometimes overlapped the bounderies of the main nuclei (Fenech, 1993) .
As a measure for toxicity, the mitotic index (MI) was determined by scoring metaphases in 3000 cells and was related to the percentage of survival of the negative control as follows:
(MI from treated sample)/(MI from negative control)X100
For genotoxicity testing, statistical differences between control and treated samples were determined with the chi-square test
The reduction of micronucleus levels (/?MN) was determined for a hederin, chlorophyllin and ascorbic acid treatments, according to Gebhart et al. (1985) , as follows. Positive control
Positive control: doxorubicin at 1.5X10" 2 nmol/ml. MNCB: binucleated cells examined (1000) containing one, two, or three or more micronuclei. n.d., not done because of its cytotoxic effect.
•Significant at 1% level {P < 0.01).
A clear antimutagenic effect was assumed only for /? M N values <0.75; a slight antimutagenic effect for R MN values between 0.75 and 0 85; and no effect with /f MN > 0.85.
In antimutagenicity screening, statistical differences between controls (Dox) and treated samples (Dox + Clo; Dox + Hed;Dox + AsA) were also determined using the chi-square test.
Results
The cytotoxic and genotoxic (clastogenic or aneugenic) effects of a-hederin and ascorbic acid are presented in Table II . The results showed no cytotoxicity for a-hederin whereas a doserelated decrease in the division rate was shown for ascorbic acid at the highest dose of 10 4 nmol/ml, indicating a cytotoxic effect. However, neither clastogenic nor aneugenic activities could be detected for both substances in human lymphocytes.
Previous studies concerning chlorophyllin did not show any cytotoxicity (1.3X10" 4 , 1.3X1O" 3 , 1.3X10" 2 , 0.13, 1.3 and 13 nmol/ml) and any clastogenicity or aneuploidy, at the same concentrations (Ait Amara- Mokrane et al., 1995) .
The antimutagenic activity of a-hederin, chlorophyllin and ascorbic acid against doxorubicin was determined using an adapted protocol of treatment as shown in Figure 1 , and data concerning the anticlastogenic activities of these antimutagenic agents are presented in Tables En, IV and V. Alpha-hederin exerted an antimutagenic effect against doxorubicin in the simultaneous treatment with pre-incubation at all concentrations (1.3X1O" 2 , 0.13, 1.3 and 13 nmol/ml) and in the simultaneous treament without pre-incubation at 0.13 nmol/ml. Alpha-hederin was also effective, in pre-treatment with PHA stimulation (la) and in pre-treatment at 24 h of culture (Ic), at all concentrations, and in pre-treatment at 18 h of culture (Ib) only at 0.13 and 1.3 nmol/ml. No antimutagenic effect could be found post-treatment.
Chlorophyllin exhibited antimutagenic activity in the simultaneous treatment with pre-incubation at all concentrations (0.14; 1.4 and 14 nmol/ml), and in post-treatment at 26 h of culture (TJIa). No clear dose-related effect was observed for both a-hederin and chlorophyllin.
Ascorbic acid was effective in reducing the micronucleus levels only in the simultaneous treatment with pre-incubation. Abbreviations used throughout the tables: Dox: doxorubicin; Clo: chlorophyllin; Hed: a-hederin and AsA: ascorbic acid. Hed I: I.3X10" 2 nmol/ml; Hed 0.13 nmol/ml; Hed III: 1.3 nmol/1; Hed IV: 13 nmol/ml. MNCB: binucleated cells examined (1000) containing one, two, three or more micronuclei.
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•Significant at the 5% (P < 0.05), ** 1% (P < 0.01) and **• 0.1% levels (P < 0.001) respectively.
•Negative control.
•"Control. Clo I: 0.14 nmol/ml; Clo 11:1.4 nmol/ml; Clo III: 14 nmol/ml. MNCB: binucleated cells examined (1000) containing one, two, three or more micronuclei.
•Significant at the 5% (/> < 0.05), ** 1% (P < 0.01) and ••• 0.1% levels (P < 0.001) respectively.
•Negative control. b Control.
?MN values are reported in Table VI . Results showed a clear anticlastogenic effect (R MN < 0.75) for a-hederin in all pretreatments (la, Ib and Ic), and in simultaneous treatments with and without pre-incubation (Ha and lib). Clear anticlastogenic activity was also observed for chlorophyllin in the simultaneous treatments with and without pre-incubation, and in posttreatments Ida and mb.
The influence of a-hederin, chlorophyllin and ascorbic acid on doxorubicin-induced cytotoxicity in human lymphocytes is reported in Table VII . The results showed a slight increase in 164 the cytotoxicity of a-hederin, chlorophyllin and ascorbic acid, in combination with doxorubicin.
Discussion
The data obtained in the present study confirmed the antimutagenic activity of a-hederin and chlorophyllin previously observed in the Salmonella/microsomal assay. Both substances prevented mutagenesis induced by benzo[a]pyrene and indirectly that of urine from smokers containing 2-amino-7-Protective effects of o-hederin, chlorophyllin and ascorbic add Table V . Effect of various treatments with ascorbic acid (10 nmol/ml) on the frequency of micronuclei induced by doxorubicin (1.5X1O" 2 nmol/ml) MNCB: binucleated cells examined (1000) containing one, two, three or more micronuclei. "Significant at the 1% level (P < 0.01). "Negative control. ''Control. naphthol, a bladder carcinogen (Elias et al, 1990) . Comparable antimutagenic effects were reported for both chlorophyllin, the synthetic sodium-copper salt of chlorophyll, and chlorophyll per se, which have been shown to reduce or eliminate the in vitro mutagenicity of several mutagens (benzo[a]pyrene, 2-aminoanthracene and aflatoxin B[) and complex mixtures such as amino acid pyrolysis products, cigarette smoke condensate, extracts of coal dust, diesel emission particles and airborne particles (Arimoto et al, 1980; Lai et al, 1980; Munzer, 1981; Katoh et al, 1983; Terwel and Van derHoeven, 1985; Ong et al, 1986; Elias et al, 1990; Warner et al, 1991; Hayatsu et al, 1993) . The antimutagenic activity of chlorophyllin in vitro has been confirmed in a variety of in vivo systems, such as the reduction of covalent binding of 2-amino-3-methylimidazo-4,5-quinolone to rat liver DNA (Dashwood, 1992) and of binding of aflatoxin B| in the liver of trout (Dashwood et al, 1991) , the decrease of y-ray-induced sister chromatid exchange in bone marrow cells (Morales-Ramirez and Garcia-Rodriguez, 1994 ) and in Drosophila (Hayatsu et al, 1993) , and the inhibition of the clastogenic effect of cesium and methyl mercury chloride in mice (Gosh et al, 1991a, b) . Chlorophyllin demonstrated antimutagenicity towards a wide range of mutagens. This compound is an antioxidant and may act as a radical scavenger (Sato et al, 1984) . Several other mechanisms have been suggested, including suppression of metabolic activation, and inactivation due to complex formation with either the metabolically activated mutagen or a nonactivated precursor (Arimoto et al, 1980 (Arimoto et al, , 1993 Ong et al, 1986; Arimoto and Hayatsu, 1989; Negishi etal, 1989; Romert Hayatsu et al, 1993) . In the present study, chlorophyllin was effective in the simultaneous treatments with and without pre-incubation, suggesting a desmutagenic effect (Kuroda et al, 1992) . R MN values < 0.75 (0.48 and 0.63 for 0.14 nmol/ml Clo; 0.60 and 0.66 for 1.4 nmol/ml Clo; and 0.53 and 0.65 for 14 nmol/ml Clo respectively in posttreatments Ilia and nib) showed an anticlastogenic activity in post-treatment, suggesting that chlorophyllin could be involved in the DNA repair process (Kada and Shimoi, 1987; De Flora and Ramel, 1988) . These data are in agreement with the results found by Bronzetti et al. (1990) , who ascribed chlorophyllin to a larger class of desmutagens, in particular those acting inside and outside the cell. In fact, chlorophyllin acted as a bio-antimutagen and as a desmutagen, inactivating mutagens chemically or enzymatically. The possibility for an antimutagen to act through multiple mechanisms has been shown by De Flora and Ramel (1988) . Alpha-hederin showed a statistical decrease in the frequency of micronuclei in all pre-treatments (la, Ib and Ic), and in simultaneous treatments with and without pre-incubation. It exerted an anticlastogenic activity through different mechanisms of action, as shown for chlorophyllin. This saponin exhibited a clear desmutagenic activity by its efficiency in the simultaneous treatments, and also provided, by its efficiency in the pre-treatments, the possibility of inducing metabolic enzymes into acting as metabolic inactivators for the mutagen.
The absence of a dose-effect relationship observed in the antimutagenic data could be attributed to the various mechanisms of action exhibited by a-hederin and chlorophyllin at different concentrations.
Ascorbic acid was effective in reducing the clastogenic activity of doxorubicin only in the simultaneous treatment with pre-incubation, suggesting a clear desmutagenic activity. This result is in agreement with the data of Kuroda (1990) , who showed the efficiency of ascorbic acid as a desmutagen in reducing ethyl methanesulphonate (EMS)-induced mutations in Chinese hamster V79 cells. Similar results were found in vitro in human lymphocytes: a clear decrease in trenamonbreakage was observed in the simultaneous treatment with ascorbic acid (Gebhart et al., 1985) . The antimutagenic activity of ascorbic acid has often been attributed to its antioxidative property; however, during a comparative study, chlorophyllin was found to be more efficient as an antimutagen than powerful antioxidants such as retinol, p-carotene, ascorbic acid and oc-tocopherol (Ong et al, 1989) . This could explain the possibility that ascorbic acid exerts an antimutagenic effect by a different mechanism of action, as shown by Shamberger (1983) in the competition between nitroso compounds and ascorbic acid. Doxorubicin-induced cytotoxicity was increased with a hederin, chlorophyllin and ascorbic acid treatments. These results suggested that no protective effect was displayed by the three antimutagenic substances in human lymphocytes on the cytotoxicity induced by doxorubicin. These results are in contrast with the data reported by Kuroda (1990) , who showed a protective effect for ascorbic acid on EMS-induced cytotoxicity in Chinese hamster V79 cells. The increase in the cytotoxicity could be due to the interaction between chemicals present in the culture, since no cytotoxicity was exhibited by the antimutagenic substances themselves.
In summary, the clear anticlastogenic effect of a-hederin, chlorophyllin and ascorbic acid on the action of an intercalating agent and the low cytotoxicity of these biological molecules supported the idea of the possibility of a practical application of natural protectors against the clastogenic action of chemical agents.
